medigraphic.com
ISSN 1561-3194 (Electronic)

2012, Number 2

<< Back Next >>

Rev Ciencias Médicas 2012; 16 (2)

Relation between anthropometric characteristics and its repercussion in Diabetes Type-2

Zubizarreta PK, Rodríguez GN, Castilla RAB, Hevia CM, Becerra ZN

Language: Spanish
References: 20
Page: 3-19
PDF size: 127.25 Kb.


ABSTRACT

The interrelation between obesity and type-2 diabetes mellitus is very important from the clinical and epidemiological view point. This study was aimed at assessing the association between the vascular risk and the anthropometric variables in patients with type-2 diabetes mellitus, where the body-mass index and the abdominal size were evaluated in relation to the presence of chronic vascular complications in these patients. One hundred twenty (120) patients from 40 to 79 years old, attending to the diabetes mellitus office at "Hermanos Ameijeiras" University Hospital from October 2009 to September 2010 were included in the study considering the medical history, complementary and general clinical examinations. Body-mass index, abdominal size (AS), insulinemia and C-peptide were also determined; (IMC ≥ de 30 kg/m2 sc) was taken as obesity risk and the augmented abdominal size (in men › 102 cm and in women › 88) and these values were related to vascular complications together with C-peptide and insulinemia on empty stomach. Results were statistically analyzed having a significance of p ‹ 0.05. Obesity (48,3%) and abdominal size (67,5%) prevailed. Both, the obese ones and those presenting high C-peptide values and insulinemia showed no differences among them. Vascular chronic complications prevailed in type-2 diabetic patients and in those with augmentation of the abdominal fat.


REFERENCES

  1. Bloomgarden ZT. Third Annual World Congress on the Insulin Resistance Síndrome: mediators, antecedents and measurement. Diabetes Care [revista en la Internet] 2006 [citado 2010 Mar 20]; 29(9):2165-9. Disponible en: http://care.diabetesjournals.org/content/29/9/2165.full.pdf+html

  2. Cuba. Ministerio de Salud Pública. Dirección Nacional de Estadísticas. Principales causas de muerte de todas las edades. Ciudad de la Habana: MINSAP; 2005. 20-4.

  3. Abdul-Ghani MA, Tripathy D, Defronzo RA. Contributions of Beta cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care. [revista en la Internet] 2006 [citado 2010 Feb 23]; 29(5):1130-9. Disponible en: http://care.diabetesjournals.org/content/29/5/1130.full.pdf+html

  4. Alberti KG, Zimmet PZ, Shaw JE. The metabolic syndrome, a new wordlwide definition from the International Diabetes Federation consensus. Lancet. [revista en la Internet] 2006 May [citado 2010 Ene 12]; 23(5):469-80. Disponible en: http://onlinelibrary.wiley.com/doi/10.1111/j.1464-5491.2006.01858.x/pdf

  5. Koster A, Leitzmann M, Schatzkin A, Mouw T, Adams K, Hollenbeck A, et al. Waist circumference and mortality. Am J Epidemiol. [Internet] 2008 Jun [Access 2009 Dic 13]; 167(12):1465-75. Disponible en: http://aje.oxfordjournals.org/content/167/12/1465.full.pdf+html

  6. Lomtadze I, Virsaladze D, Koplatadze M, Mikashavidze T. The relation of insulin resistance with the complications of diabetes mellitus type 2 and metabolic parameters. Georgian Med News. [Internet] 2008 Jan [Access 2010 Abr 30]; (154):26-9. Disponible en: http://www.mendeley.com/research/intact-total-proinsulin-new-aspects-diagnosis-treatment-type-2-diabetes-mellitus-insulin-resistance/

  7. Cuba. Ministerio de Salud Pública. Programa Nacional de Prevención, Diagnóstico, Evaluación y Control de la Hipertensión Arterial: Guía para la atención médica [Internet]. La Habana: MINSAP; 2006 [citado 11 Feb 2010]. Disponible en: http://www.hta.sld.cu/node/44

  8. Garrow JS, Webster J. Quetelet's Index (W/H2) as a measure of fatness. Int J Obes. 1985; 9(2):147-53.

  9. Socarrás Suárez MM, Bolet Astoviza M, Licea Puig ME. Obesidad: Tratamiento no farmacológico y prevención. Rev Cubana Endocrinol [revista en la Internet]. 2002 Abr [citado 2012 Mar 21]; 13(1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-29532002000100005&lng=es

  10. Sierra ID, Mendivil CO, Hernández B. Manual de manejo integral del riesgo cardiovascular. 2 ed. Bogotá: Horizontes; 2003. 15-9.

  11. Asociación Latinoamericana de diabetes. Guías ALAD 2006 de diagnóstico control y tratamiento de la Diabetes Mellitus Tipo 2 [internet]. OPS; 2006: Disponible en: http://www.sld.cu/galerias/pdf/sitios/diabetes/guias_alad_de_diagnostico_y_tratamiento_de_la_diadetes_tipo_2%282006%29.pdf [citado 12 Feb 2011]

  12. Kashyap SR, Defronzo RA. The insulin resistance syndrome: physiological considerations. Diabetes Vasc Dis Res. [revista en la Internet] 2007 Mar [Access 2010 May 31];4(1):13-9. Disponible en: http://dvr.sagepub.com/content/4/1/13.full.pdf+html

  13. Sereday M, Damiano M, Lapertosa S. Complicaciones crónicas en personas con diabetes mellitus tipo 2 de reciente diagnóstico. Endocrinol Nutr. [revista en la Internet] 2008 [citado 09 Feb 2010]; 55(2):64-8. Disponible en: http://www.elsevier.es/sites/default/files/elsevier/pdf/12/12v55n02a13115563pdf001.pdf

  14. Valdés Ramos E, Bencosme Rodríguez N. Frecuencia de la hipertensión arterial y su relación con algunas variables clínicas en pacientes con diabetes mellitus tipo 2. Rev Cubana Endocrinol [revista en la Internet]. 2009 Dic [citado 2010 Ene 07]; 20(3): 77-88. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-29532009000300002&lng=es

  15. Aschner P, Ruiz A, Balkau B, Massien CH, Haffner S. Association of abdominal adiposity with diabetes and cardiovascular disease in Latin America. J Cardiometab Hypertens. [revista en la Internet] 2009 Dec [citado 2010 Ene 08]; 11(12):769-74. Disponible en: http://onlinelibrary.wiley.com/doi/10.1111/j.1559-4572.2008.00051.x/pdf

  16. Dallongeville J, Bringer J, Bruckert E, Charbonnel B, Dievart F, Komajda M, et al. Abdominal obesity is associated with ineffective control of cardiovascular risk factors in primary care in France. Diabetes Metab. [Internet] 2008 Dec [Access 2010 Feb 06]; 34(6 Pt 1):606-11. Disponible en: http://www.em-consulte.com/article/195995/alertePM

  17. Vasques AC, Pereira PF, Gomide RM, Batista MCR, Campos MTFS, Sant'Ana LFR. et al. Influência do excesso de peso corporal e da adiposidade central na glicemia e no perfil lipídico de pacientes portadores de diabetes mellitus tipo 2. Arq Bras Endocrinol Metab [serial on the Internet]. 2007 Dec [cited 2012 Mar 21];51(9): 1516-1521. Available from: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27302007000900015&lng=en

  18. Calderín Bouza RO, Orlandi González N. Síndrome metabólico vs síndrome de insulinorresistencia. Diferentes términos, clasificaciones y enfoques: ¿existe o no? Rev Cubana Endocrinol [revista en la Internet]. 2006 Dic [citado 2012 Mar 21]; 17(3): Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-29532006000300006&lng=es

  19. Rosenzweig J, Ferrannini E, Grundy S, Haffner S, Heine R, Horton E, et al. Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. [Internet] 2008 Oct [Access 2010 May 14] 93(10):3671-89. Disponible en: http://jcem.endojournals.org/content/93/10/3671.long

  20. American Diabetes Association. Standards of medical care in diabetes: VIII diabetes care in specific settings. Diabetes Care. 2005; 33(Supl 1):S24-8.




2020     |     www.medigraphic.com